autologous clonal neoantigen T cells ATL001
Term · Oncology and biomedicine · MLC-T-ONC-011572
A preparation of personalized tumor-derived T-lymphocytes composed of tumor infiltrating lymphocytes (TILs) that are reactive to clonal cancer neoantigens, with potential immunostimulating and antineoplastic activities. The TILs are removed from the suppressive tumor microenvironment (TME) and re-activated. Upon reintroduction into the patient, the clonal neoantigen T (cNeT) cells recognize and bind to tumor cells expressing the targeted neoantigen, resulting in a cytotoxic T-lymphocyte (CTL)-mediated immune response against the patient's tumor cells.
| Identifier | MLC-T-ONC-011572 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | autologous cNeT ATL001 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011572",
"term": "autologous clonal neoantigen T cells ATL001",
"field": "Oncology and biomedicine",
"definition": "A preparation of personalized tumor-derived T-lymphocytes composed of tumor infiltrating lymphocytes (TILs) that are reactive to clonal cancer neoantigens, with potential immunostimulating and antineoplastic activities. The TILs are removed from the suppressive tumor microenvironment (TME) and re-activated. Upon reintroduction into the patient, the clonal neoantigen T (cNeT) cells recognize and bind to tumor cells expressing the targeted neoantigen, resulting in a cytotoxic T-lymphocyte (CTL)-mediated immune response against the patient's tumor cells.",
"synonyms": [
"autologous cNeT ATL001"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/autologous-clonal-neoantigen-t-cells-atl001/"
}
Record 2,906 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.